• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Inverness Medical Innovations

edit

Inverness Medical Innovations, Inc. engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products, as well as a range of vitamins and nutritional supplements. The company’s Professional Diagnostics segment offers preventive and interventional medical test products in the areas, such as cardiology, women’s health, oncology, infectious disease, and drugs of abuse. Its Health Management segment provides wellness programs, including health and productivity assessment, healthy living programs, health portal and personal health record, and health coaching and risk screenings; disease management program; oncology program; and obstetrical care services, and home-based obstetrical programs. The company’s Consumer Diagnostics segment offers a range of consumer products, including home diagnostic tests, cholesterol tests, glucose products, and treatment for bacterial vaginosis. Its vitamins and Nutritional Supplements segment offers vitamins and nutritional supplements, including Stresstabs, a B-complex vitamin with added antioxidants; Ferro-Sequels, a time-release iron supplement; Protegra, an antioxidant vitamin and mineral supplement; Posture-D, a calcium supplement; SoyCare, a soy supplement for menopause; ALLBEE, a line of B-complex vitamins; and Z-BEC, a zinc supplement with B-complex vitamins and added antioxidants. The company sells and markets its products through sales forces, distributors, and channel partners to hospitals, reference laboratories, physicians’ offices and other point-of-care settings, self-insured employers, pharmaceutical companies, retail drug stores, groceries, mass merchandisers, and warehouse clubs. It has operations in the United States, Canada, the United Kingdom, Germany, Italy, Spain, the Netherlands, France, Austria, India, Japan, China, Australia, South Africa, Brazil, Colombia, and Israel. The company was founded in 2001 and is headquartered in Waltham, Massachusetts.

Recent Milestones

edit

• 
  Inverness Medical Innovations received $63.4M in Venture Round funding. (1/19/10)
  Posted 1/20/10 at 2:09am via masshightech.com
• 
  Inverness Medical Innovations added Ron Zwanziger as Chairman & CEO.
  Posted 1/20/10 at 2:05am
• 
  Went public with stock symbol NYSE:IMA.
  Posted 1/20/10 at 2:05am
• 
  Inverness Medical Innovations added David Teitel as CFO.
  Posted 1/20/10 at 2:05am

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/20/10

Stock Price

Sources

1. Inverness sells nutritionals units for $63M (masshightech.com) [edit]